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Phosphorothioate Anti-sense Oligonucleotides:  The Kinetics and 
Mechanism of the Generation of the Sulfurising Agent from 
Phenylacetyl Disulfide (PADS) 
James Scotson
a
, Benjamin I. Andrews
b
, Andrew P. Laws
a
 and Michael I. Page
a
  
The synthesis of phosphorothioate oligonucleotides is often accomplished in the pharmaceutical 
industry by the sulfurisation of the nucleotide-phosphite using phenylacetyl disulfide (PADS) which has 
an optimal combination of properties. This is best achieved by an initial ‘ageing’ of PADS for 48 hrs in 
acetonitrile with 3-picoline to generate polysulfides. The initial base-catalysed degradation of PADS 
occurs by an E1cB-type elimination to generate a ketene and acyldisulfide anion. Proton abstraction to 
reversibly generate a carbanion is demonstrated by H/D exchange, the rate of which is greatly 
increased by electron-withdrawing substituents in the aromatic ring of PADS. The ketene can be 
trapped intramolecularly by an o-allyl group. The disulfide anion generated subsequently attacks 
unreacted PADS on sulfur to give polysulfides, the active sulfurising agent. The rate of degradation of PADS is 
decreased by less basic substituted pyridines and is only first order in PADS indicating that the rate-limiting 
step is formation of the disulfide anion from the carbanion. 
 
Introduction 
Synthetic oligonucleotides have been used in many different ways 
for several decades
1
, such as therapeutic agents and in diagnostics. 
An anti-sense oligonucleotide (ASO) is usually a single-stranded 
deoxy-ribonucleotide (usually 15-35 base pairs in length) which is 
complementary to a target mRNA. Complex dimer formation 
between the ASO and the target mRNA through normal Watson-
Crick base pairing can lead to inhibition of translation and so 
prevent synthesis of an unwanted target protein. The formation of 
the ASO–mRNA hetero-duplex often activates RNase H 
endonuclease activity which then catalyses the hydrolysis of the 
mRNA leaving the ASO intact
2
. The first approved anti-sense 
oligonucleotide was Vitravene (formiversen, for treating the 
blinding viral condition cytomegalovirus induced retinitis afflicting 
some of those infected with HIV
3
), which was followed by 
numerous clinical trials of other oligonucleotides
4
 and, more 
recently, Kynamro (mipomersen) to treat genetically inherited high 
cholesterol levels
5
. Other mechanisms of action of ASOs include 
‘exon-skipping’ where, instead of binding to mRNA, the ASO binds 
to longer pre-mRNA chains sterically blocking an unwanted 
mutation and its surrounding sequence preventing the exon, 
containing the mutation, being spliced into the mRNA. Antisense-
mediated exon skipping is a promising therapeutic for 
neuromuscular diseases 
6
, although trials for drisapersen to treat 
Duchenne Muscular Dystrophy have recently been stopped. ASOs 
are also useful as valuable genetic diagnostic tools, for example, 
HyBeacon probes are single-stranded oligonucleotides with one or 
more internal bases labelled with a fluorescent dye so that when 
duplex formation occurs with its target sequence there is an 
increase in fluorescence
7
. 
However, the use of phosphodiester anti-sense oligonucleotides is 
limited because they are rapidly hydrolysed by intracellular 
endonucleases and exonucleases
8
. Consequently, ASOs have been 
modified to decrease their susceptibility to nuclease cleavage and 
to increase their uptake into cells, binding efficiency, bio-stability 
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and potency
9
.  Examples of these modifications are the inclusion of 
phosphorothioate backbones (1)
10
 and changes to the 2′ position of 
the ribose sugar (e.g. 2′-O-methoxyethyl) or the sugar-phosphate 
(e.g. morpholino and locked nucleic acid,  (S)-constrained-2′-O-ethyl 
- bicyclic constrained riboses)
11
. These changes do not disrupt H-
bonding between the nucleobases.  
 
Phosphorothioates (1) are the most widely investigated 
oligonucleotides because of their relative nuclease stability and 
ease of synthesis and a naturally occurring phosphorothioate has 
even been found in bacterial DNA
12
. The replacement of one of the 
phosphate non-bridging oxygens by sulfur introduces chirality at 
phosphorus and it is only the (S)-P phosphorothioate diastereomer 
that is nuclease resistant
13
. However, phosphorothioate 
oligonucleotides can reduce the affinity of the ASO for its mRNA 
target as shown by the melting temperature of the ASO-mRNA 
hetero-duplex which is decreased by approximately 0.5
o
C per 
nucleotide
14
. Conversely, the introduction of the hydrophobic sulfur 
increases cell uptake compared with the wild-type phosphodiester. 
Phosphorothioate oligonucleotides remain highly water soluble, still 
bind well to mRNA and activate RNase H making them the most 
common modification of ASOs undergoing clinical trials.  
The synthesis of phosphorothioate oligonucleotides is often 
accomplished by the sulfurisation of the nucleotide-phosphite 
through reaction of the corresponding P(III) analogue, usually 
attached to a solid support, with an organic sulfurising agent 
which is present in an organic solvent. As with all the steps 
involved in the synthesis of oligonucleotide based 
phosphorthioates, the sulfurisation step of the synthesis should 
be be rapid, have a near quantitative yield and give a maximal 
P=S to P=O ratio. The sulfurisation of phosphorus(III) 
compounds has been achieved with a number of reagents such 
as: phenylacetyl disulfide (PADS) (2),
15
 3H-1,2-benzodithiol-3-
one-1,1-dioxide (Beaucage reagent),
16
 tetraethylthiuram 
disulfide (TETD),
17
 dibenzoyl tetrasulfide
18
, bis-(O,O-
diisopropoxyphosphinothioyl) disulfide (S-Tetra),
19
 
benzyltriethylammonium tetrathiomolybdate (BTTM)
20
, bis-(p-
toluenesulfonyl) disulfide,
21
 3-ethoxy-1,2,4-dithiazoline-5-one 
(EDITH) and 1,2,4-dithiazolidine-3,5-dione (DTSNH),
22
 
bis(ethoxythiocarbonyl)tetrasulfide,
23
 3-methyl-1,2,4-
dithiazolin-5-one (MEDITH)
24
 and 3-amino-1,2,4-dithiazole-5-
thione (ADTT, xanthane hydride).
25
  
Although PADS (2) has an optimal combination of properties and 
is often used as the sulfurising reagent in the pharmaceutical 
industry
26,27
, there have been very few mechanistic studies of 
the sulfurisation reactions of phosphorus (III) analogues using 
PADS. In particular, PADS must be ‘aged’ in a basic acetonitrile 
solution to obtain optimal sulfurisation activity
28
 and the 
reasons for this are not understood. Herein we report the 
results of our kinetic and mechanistic studies which identify the 
actual sulfurising agent and suggest an unexpected pathway for 
its generation. Elsewhere we describe the kinetics and 
mechanism of the sulfurisation step of substituted triphenyl 
phosphites and trialkyl phosphites using PADS
29
.  
 
Results and Discussion 
It is known that a freshly made solution of PADS (2) is not an 
optimal sulfurising agent
26
. Solutions of PADS usually consist of 50% 
v/v 3-picoline in acetonitrile or other bases such as pyridine or 
collidine but their efficiency improves greatly upon ‘ageing’ for 
about 2 days
26
. PADS degrades completely over this period of time 
as shown byHPLC, 
1
H NMR and MS and the colour of the solution 
changes dramatically from pale yellow through green/blue to 
brown/black over about 5 days. The pseudo first-order rate 
constants for the sulfurisation of 0.05 M triphenyl phosphite in 
acetonitrile by 0.5 M PADS with 1.0 M 3-picoline increase with the 
length of ‘ageing’ (Fig. 1), such that PADS ‘aged’ for 48 hrs. is 13-
fold more active than a freshly prepared solution of PADS. It is 
apparent therefore that the degradation product(s) of PADS are 
more efficient sulfurising agents, but their identity is not known. 
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The exponential rate of degradation of 3.3 M PADS (2) in 
acetonitrile 25
o
C was followed by HPLC and the associated first-
order rate constants depend on the concentration of 3-picoline (Fig. 
2). This increase in rate is unlikely to be a consequence of a change  
 
Figure 1 The pseudo first-order rate constants for the 
sulfurisation of triphenyl phosphite (0.05 M) to (PhO)3P=S 
by (0.5 M) PADS (2) as a function of the time that PADS has 
been ‘aged’ in acetonitrile with (1.0 M) 3-picoline at 25
o
C  
 
in the dielectric constant of the solution as, for example, PADS is 
stable in a solution of acetonitrile / dimethylsulfoxide 90/10% v/v 
over 24 hrs. Furthermore, the rate of degradation of PADS in 
acetonitrile increases with the basicity of the pyridine base. The 
slope of the dependence of the observed pseudo first-order rate 
constants for the decomposition of PADS (2) (Fig. 2) gives the 
associated second-order rate constant. These rate constants for the  
 
Figure 2 The dependence of the pseudo first-order rate 
constants for the decomposition of PADS (2) in acetonitrile on 
the concentration of 3-picoline at 25
o
C. 
‘ageing’ of PADS by substituted pyridines (Table 1) generate a 
Bronsted β-value of 0.37 based on the estimated pKa in 
acetonitrile
30
. This is compatible with the pyridine acting as either 
a base or as a nucleophile with little charge development on the 
basic nitrogen. The rate of degradation of PADS in acetonitrile is 
faster with a more basic amine, e.g. with 1.0 M triethylamine it is 
complete within 5 mins. 
 
Table 1 The second-order rate constants for the decomposition 
of PADS (2) in acetonitrile (ACN) as a function of the basicity of 
substituted pyridines in ACN at 25
o
C. 
Pyridine 
substituent 
pKa (ACN) conjugate 
acid 
kcat (M
-1
s
-1
) 
4-MeO 14.73 7.76 x 10
-6
 
3-Me 13.70 3.34 x 10
-6
 
H 12.60 1.63 x 10
-6
 
3-MeO 12.45 3.79 x 10
-7
 
4-CN 8.50 3.76 x 10
-8
 
2,6-diMe2 14.72 4.44 x 10
-6
 
 
The products of the ‘ageing’ of PADS are a mixture of 
diacylpolysulfides and acylpolysulfide anions. HPLC-mass 
spectroscopy data performed on aged PADS solutions showed the 
presence of m/z values corresponding to a variety of 
diacylpolysulfides, in particular the tri-sulfide (3) at m/z = 357 (Na
+
 
adduct) and the penta-sulfide (4) at m/z = 437 (K
+
 adduct). After 
several days elemental sulfur crystallised from the solution. The 
diphenylacetyl polysulfides are presumably formed from 
nucleophilic attack of the disulfide anion on PADS at sulfur. It is 
known that disulfide anions are better nucleophiles than the 
corresponding thiolate
31
. The formation of phenylacetyl disulfide 
anion (5) could result from either nucleophilic attack on PADS or a 
general-base catalysed elimination reaction of PADS by the picoline 
base. It is likely that there is an equilibrium set up between the 
diacylpolysulfides and acylpolysulfide anions and sulfur
32
. 
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Nucleophilic attack on PADS (2) by picoline would generate an 
acyl-picolinium ion intermediate (6) but no direct experimental 
evidence for this could be found nor could its presence be 
inferred from trapping experiments with a variety of 
nucleophiles. However, the general-base catalysed formation of 
the disulfide anion by an E1cB - type mechanism (Scheme 1) is 
indicated by both D-exchange and trapping of the ketene 
intermediate. 
 
 
The rate of H/D exchange was measured by 
1
H NMR using a 
solution of 0.17M PADS (2) in d3-acetonitrile containing various 
concentrations of 3-picoline and 0.6M D2O at 25
o
C. The CH2 singlet 
at δ 4.15 ppm disappeared with a first-order decay generating a 
triplet for CHD at δ 4.13 ppm which reached a maximum intensity 
followed by its disappearance to give CD2. The pseudo first-order 
rate constants for D-exchange showed a first-order dependence on 
the concentration of 3-picoline (Fig. 3) which gives a second-order 
rate constant kpic = 4.72 x 10
-3
 M
-1
s
-1
. 
The mechanism of D-exchange presumably occurs through the 
formation of the intermediate carbanion. The relatively low 
dielectric constant of the solvent may mean that the ionization of 
this carbon acid may give rise to ion-pairs in equilibrium with the 
dissociated species (Scheme 2), where the product KiKd corresponds 
to the normal ionization constant Ka. However, it is unlikely that 
exchange can occur from the ion-pair and so if isotopic exchange 
occurs with the dissociated carbanion, then the rate of protonation 
of the carbanion k-2 can be assumed to be diffusion-controlled
33
, 
which, based on a viscosity of 0.35cP for acetonitrile  can be 
assumed to be ~ 10
10 
M
-1
s
-1
. The pKa value for PADS in 
acetonitrile/water (90/10% v/v) can then be calculated to be 26.0 
 
Figure 3 The dependence of the pseudo observed first-order 
rate constants for the H/D - exchange of PADS on the 
concentration of 3-picoline in acetonitrile at 25
o
C. 
 
by using this estimated diffusion-controlled rate constant, the 
measured rate of D-exchange and the pKa of 13.7 for 3-picoline in 
acetonitrile
34
. There are no pKa data for thioesters in acetonitrile 
but that for ethyl thioacetate in water is 21
35
 and, based on 
substituent and solvent effects
30
, that for ethyl thiophenylacetate 
PhCH2COSEt in acetonitrile is ~ 31, so the estimated value of 26.0 
for PADS is reasonable given the additional electron-withdrawing 
SSCOCH2Ph residue. 
  
 
 
The rate of degradation of PADS (2) is ca. 500-fold slower than the 
rate of D-exchange under the same conditions, indicating that 
carbanion formation is relevant to the formation of the degradation 
products of PADS. Indeed, removing the dissociable protons in 
PADS by α,α dimethylation prevents the degradation of the 
tetramethyl derivative 7 which remains unchanged after 1 week in 
acetonitrile with 5 equivalents of picoline at 25
o
C. Similarly, bis-
0.0
1.0
2.0
3.0
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1
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3
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benzoyl disulfide is stable in acetonitrile with 5 equivalents of 
picoline at 25
o
C for 1 week, confirming the elimination mechanism 
for the degradation of PADS (2). 
 
The proposed mechanism for the degradation of PADS (Scheme 1) 
involves the generation of the ketene intermediate. The reaction of 
o-allyl PADS (8) in 50% v/v acetonitrile/3-picoline yields the bicyclic 
ketone (9) identified by MS and 
1
H NMR, consistent with trapping 
the intermediate ketene by a [2+2] cycloaddition. With PADS itself, 
the ketene forms the 3-hydroxycyclobutenone dimer, (10) and the 
pyrononone trimer (11) as observed with the base-catalysed 
reaction of phenylacetyl chloride
36
. 
 
 
OPh
PhHO
10
O
O
Ph
OHPhCH2
Ph
11  
The relative effect of substituents in the aromatic ring of PADS (2) 
on the rate constants for H/D-exchange and the degradation 
process are shown in Table 2.  
 
Table 2 The dependence of the second-order rate constants 
for H/D-exchange and for the degradation of substituted 
PADS (2) in acetonitrile at 25
0
C 
PADS substituent σ kex (M
-1
s
-1
) 
4-MeO -0.27 1.38 x 10
-3
 
H 0 5.16 x 10
-3
 
4-Cl 0.23 2.20 x 10
-2
 
4-CN 0.66 1.09 x 10
-1
 
 
All of the above observations suggest that a polar mechanism is 
taking place, which is also supported by the rate of degradation of 
PADS (2) being unaffected by light or dark or the addition of the 
radical scavenger 2,6-di-tert-butyl-4-methylphenol (BHT).  
 
In summary, the degradation of PADS (2) in acetonitrile catalysed by 
pyridine bases involves reversible carbanion formation, which 
expels acyl disulfide anion to generate a ketene intermediate. The 
disulfide anion then attacks unreacted PADS at sulfur to give 
polysulfides (Scheme 3). Other possibilities are feasible, including 
polysulfide anion attack on PADS (2) and diacylated polysulfides. It 
is interesting that the rate of degradation is only first order in PADS 
(2) indicating that the rate-limiting step is k2 formation of the 
disulfide anion from the carbanion, rather than its subsequent 
reaction with a second mole of PADS. 
 
 
 
 
Conclusion 
The activation of PADS by its ‘ageing’ for 48 hrs in acetonitrile 
with 3-picoline involves the generation of polysulfides which are 
the actual nucleotide-phosphite sulfurising agents. The initial 
base-catalysed degradation of PADS occurs by an E1cB-type 
elimination to generate a ketene and acyldisulfide anion. 
Carbanion formation from PADS is reversible, demonstrated by 
H/D exchange, the mechanism of which occurs by base catalysis 
and is greatly increased by electron-withdrawing substituents in 
the aromatic ring of PADS. The ketene can be trapped 
intramolecularly by an o-allyl group. The disulfide anion 
generated subsequently attacks unreacted PADS on sulfur to give 
polysulfides, the active sulfurising agent. The rate of degradation of 
PADS is decreased by less basic substituted pyridines and is only 
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first order in PADS indicating that the rate-limiting step is formation 
of the disulfide anion from the carbanion. 
 
 
Experimental 
NMR experiments were performed using a 400MHz Bruker Avance 
DP X400 NMR spectrometer. HPLC traces were acquired using a 
Shimadzu SIL 50AH instrument with a Luna 5μ C18 4.67x250mm 
column. The gradient used for kinetic measurements was 30-95% 
acetonitrile in water over 10 minutes followed by isocratic elution 
for a further 10 minutes. 
H/D exchange of PADS To a solution of phenylacetyl disulfide in 
deuterated acetonitrile (0.2M, 400 µl) and D2O (50 µl) was added 3-
picoline (15.5 µl, 16.2 mg, 0.17mmol). The 
1
H NMR of this mixture 
was run every 2 minutes until exchange was complete. 
General degradation kinetics of PADS A solution of PADS 
(1000ppm, 3.3mM) in HPLC-grade acetonitrile containing the 
appropriate concentration of 3-picoline was divided between 2 
HPLC vials and chromatograms were taken every 30 minutes for 48 
hours. 
General sulfurisation kinetics with ‘aged’ PADS A solution of 
PADS (1M) 50/50 v/v acetonitrile/3-picoline was left to age for 48 
hours. At T=n hrs a 1ml sample of this was removed and quenched 
with dilute hydrochloric acid (10ml, 2M) to remove the picoline as 
the protonated pyridinium ion. This was then washed with DCM (2 x 
10ml) the combined organic layers dried and the solvent removed 
under vacuum. The resulting oil was then made up to 1ml using 
deuterated acetonitrile. To an NMR tube containing triphenyl 
phosphite in deuterated acetonitrile (0.1M, 200 μL) and 3-picoline 
in deuterated acetonitrile (2M, 200 μL) was added ‘aged’ PADS 
solution (200 μL, 1M) and 
31
P NMR spectrum recorded every 90 
seconds.  
Trapping the ketene intermediate A mixture of 2,2’-allyl-2,2’-
phenylacetyl disulfide (330mg, 0.852mmol) and 3-picoline (165.6 µl, 
1.7mmol) in acetonitrile (10ml) was refluxed for 2 hr. The reaction 
was followed by HPLC and was complete after 2 hrs. The mass spec 
and NMR analysis showed evidence of the product 7,7a-dihydro-1H-
cyclobuta[a]inden-2(2aH)-one as described below. 
Synthesis  
Methyl 2′-iodo-2-phenylacetate: 2′-iodo-phenylacetic acid (5.01 g, 
19.1 mmol) and H2SO4 (98%, 1.25 ml) were dissolved in methanol 
(7.5 ml). The reaction mixture was stirred for 2.5 hr at 65
o
C, then 
diluted with 250 ml dichloromethane (DCM), extracted with water 
(2 x 100 ml) and brine (50 ml). The organic solution was dried over 
MgSO4, and gravity filtered. DCM was removed under vacuum to 
give a pale yellow oil (4.88 g, 92.6% yield). HPLC retention time 
5.397 min; 
1
H NMR (CDCl3, 400MHz) δ 3.69 (s, 3H, CH3), 3.79 (s, 2H, 
CH2), 6.92-6.96 (m, 1H, ArH), 7.22-7.32 (m, 2H, ArH), 7.83 (d, 1H, J 
7.91Hz, ArH) ppm; 
13
C NMR (CDCl3, 100MHz) δ 46.12 (CH3), 52.22 
(CH2), 101.07 (CI), 128.48 (CH), 128.94 (CH), 130.68 (CH), 137.72 
(Cq), 139.54 (CH), 170.95 (CO) ppm; IR (film) 1732.81 cm
-1
. 
Methyl 2′-allyl-2-phenylacetate
37
: methyl 2′-iodo 2-phenylacetate 
(3.0 g, 10.9 mmol), CsF (6.6 g, 43.6 mmol), and Pd(PPh3)4 (0.63 g, 
0.55 mmol) were dissolved in THF (250 ml), stirred for 30 min at 
room temperature. A solution of allylboronic acid pinacol ester (3.3 
ml, 21.8 mmol) in THF (50 mL) was added and then heated under 
reflux for 24 hr. The reaction mixture was diluted with petroleum 
ether (bpt. 60–80°C, 300mL), extracted with water (2 x 200ml) and 
the combined aqueous layers washed with petroleum ether (bpt 
60-80
o
C, 100ml). The combined organic layers were washed with 
water (100 mL), brine (100 mL), dried over MgSO4. The solvent was 
removed under vacuum to give an orange oil product (2.5 g) which 
was purified using a Biotage SP4 chromatography system fitted with 
a Biotage Snap 10 column eluting with a gradient of 0-25% ethyl 
acetate in hexane over 15 column volumes to give the product ester 
as a yellow oil (1.6 g, 77.2% yield). HPLC retention time 5.630 min; 
1
H NMR (CDCl3, 400MHz) δ 3.39 (dt, 2H, J 6.29Hz, CH2), 3.61 (s, 2H, 
CH2), 3.65 (s, 3H, CH3),  4.94-5.06 (m, 2H, CH2),  5.87-5.97 (m, 1H, 
CH),  7.14-7.23 (m, 4H, ArH) ppm; 
13
C NMR (CDCl3, 100MHz) δ 37.35 
(CH2), 38.45 (CH2), 51.94 (CH3), 115.96 (CH2), 126.65 (CH), 127.55 
(CH), 129.91 (CH), 130.65 (CH), 132.66 (Cq), 136.57 (CH2), 138.35 
(Cq), 171.95 (CO) ppm; IR (film) 1734.52 cm
-1
. 
2′-Allyl 2-phenylacetic acid: to methyl-2′-allyl 2-phenylacetate (1.7 
g, 8.9 mmol) in THF (20ml) was added an aqueous lithium hydroxide 
solution (0.4M, 20ml) and the solution stirred at room temperature 
for 3 hr after which the mixture was diluted with water (40ml) and 
extracted with DCM (2 x 20ml). The pH of the aqueous layer was 
reduced to pH 1 with HCl, extracted with DCM (2 x 20ml), dried over 
MgSO4 and the solvent removed under vacuum giving the brown oil 
product (1.7 g, 9.7 mmol, 82.9% yield). HPLC retention time 4.634 
min; 
1
H NMR (CDCl3, 400MHz) δ 3.38 (dt, 2H, J 6.37 Hz, CH2), 3.65 (s, 
2H, CH2), 4.94-5.06 (m, 2H, CH2), 5.86-5.96 (m, 1H, CH), 7.14-7.23 
(m, 4H, ArH), 10.76 (broad, s, 1H, OH) ppm; 
13
C NMR (CDCl3, 
100MHz) δ 37.5 (CH2), 38.45 (CH2), 116.22 (CH2), 126.79 (CH), 
127.96 (CH), 130.08 (CH), 130.88 (CH), 132.05 (Cq), 136.52 (CH), 
138.55 (Cq), 178.41 (CO) ppm; IR (film) 1702.49cm
-1
. 
2′,2′-Diallyl 2,2-phenylacetyl disulfide (8)
38
: sodium hydrosulfide 
(798 mg, 14.25 mmol) was dissolved in ethanol (5 ml) and chilled 
over ice. The flask was fitted with an exhaust line allowing any 
gasses generated to be scrubbed by sodium hypochlorite in a well-
ventilated fume hood. In a separate flask, to 2′-allyl 2-phenylacetic 
acid (1.0 g, 5.7 mmol) dissolved in DCM (10 ml) was added Ghosez 
reagent (1.04 g, 1.03 ml, 8.5 mmol) then stirred at room 
temperature for 30 min. and the solvent removed under vacuum to 
yield an orange oil. This oil was added to the ethanolic sodium 
hydrosulfide solution which instantly turned yellow and the 
precipitate of sodium chloride removed under vacuum filtration and 
washed with ice cold ethanol (1.5ml). To the solution, stirred over 
ice, iodine was slowly added until the colour of the suspension 
changed from white to pale brown (approximately 1 g, 7.8 mmol). 
The resulting mixture was diluted with DCM (10 ml), washed twice 
with saturated sodium thiosulfate solution (2 x 15 ml) and the 
organic layer concentrated under vacuum to yield the brown oil 
product which was purified using a Biotage SP4 chromatography 
system fitted with a Biotage Snap 10 column eluting with 25% ethyl 
acetate in hexane (Rf= 0.41) to give the product as a clear oil (384 
mg, 1 mmol, 14.1% yield). HPLC retention time 7.6 min; 
1
H NMR 
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(CDCl3, 400MHz) δ 3.41 (d, 4H, J=  6.3 Hz, CH2), 4.00 (s, 4H, CH2), 
4.96-5.60 (m, 4H, CH2), 5.88-5.98 (m, 2H, CH), 7.17-7.30 (m, 8H, 
ArH) ppm; 
13
C NMR (CDCl3, 100MHz) δ 37.51 (CH2), 46.68 (CH2), 
116.63 (CH2), 126.95 (CH), 128.58 (CH), 130.22 (CH), 130.88 (Cq), 
131.53 (CH), 136.12 (CH), 139.07 (Cq), 191.81 (CO) ppm. 
7,7a-dihydro-1H-cyclobuta[a]inden-2(2aH)-one (9): A mixture of 2′-
allyl 2-phenylacetylchloride (100 mg, 0.514 mmol) and 1-chloro-
N,N,2-trimethyl-1-propenylamine (74.7 µl, 0.56 mmol) in DCM (10 
ml) was stirred for 30 min at room temperature, triethylamine (78 
µl, 0.56 mmol) in DCM (4 ml) was added and refluxed for 2 hr. The 
reaction mixture was cooled and extracted with 2M hydrochloric 
acid (20 ml) to remove the 3-picoline. The crude bright orange oil 
product mixture was purified using a Gilson prep. HPLC system 
equipped with a phenomenex luna C18, 5µ 250 x 20 mm column. 
The mobile phase consisted of a gradient of 50-100% acetonitrile 
(0.05% TFA) in water (0.05% TFA) over 15minutes then isocratic 
elution at 50% acetonitrile (0.05% TFA) in water (0.05% TFA) for a 
further 3 minutes. The product eluted at 7.5 min. All fractions were 
combined and the solvent removed under vacuum to give the 
product as a white, crystalline solid (24 mg, 41.8% yield). HPLC 
retention time 4.775 min;
 
 
1
H NMR (d3ACN, 400MHz) δ 2 2.75-2.87 
(m, 1H, CH2), 3.05 (d, 1H, J 16.73, CH2),  3.11-3.18 (m, 1H, CH),  3.30-
3.42 (m, 1H, CH2), 3.38-3.45 (m, 1H, CH2), 4.71 (broad, s, 1H),  7.23-
7.36 (m, 4H, ArH); 
13
C NMR (ACN-d
3
, 100MHz) δ 26.18 (CH), 38.82 
(CH2), 52.32 (CH2), 71.81 (CH), 124.45 (CH), 125.50 (CH), 126.82 
(CH), 127.52 (CH), 137.6 (Cq), 143.38 (Cq), 206.13 (CO), IR (film) 
1771.39 cm
-1
. 
2,2,2′,2′-Tetramethyl 2,2′phenylacetyl disulfide (7): Sodium 
hydrosulfide (4.2 g, 75 mmol) was dissolved in ethanol (30 ml) and 
chilled over ice. The flask was fitted with an exhaust line allowing 
any gasses generated to be scrubbed by sodium hypochlorite in a 
well-ventilated fume hood. In a separate flask, to 2-phenylisobutyric 
acid (5 g, 30 mmol) dissolved in DCM (20 ml) was added Ghosez 
reagent (6.16 g, 5.6 ml, 45 mmol) then stirred at room temperature 
for 30 min. and the solvent removed under vacuum to yield an 
orange oil. This oil was added to the ethanolic sodium hydrosulfide 
solution which instantly turned yellow and the precipitate of 
sodium chloride removed under vacuum filtration and washed with 
ice cold ethanol (1.5ml). To the solution, stirred over ice, iodine (2 
g, 15.6 mmol) was slowly added. The resulting precipitate was 
collected by vacuum filtration and washed with ice-cold ethanol (5 
ml) and water (10ml) to give a waxy yellow solid (2.2 g, 5.9 mmol, 
39.3 % yield). HPLC retention time 7.6 min; 
1
H NMR (CDCl3, 
400MHz) δ 1.68 (s, 12H), 7.34 (m, 10H) ppm; 
13
C NMR (CDCl3, 
100MHz) δ 26.82, 54.21, 127.27, 127.86, 128.61, 142.14, 199.39 
ppm. HRMS (m/z): [M+NH4]
+
 for C20H22O2S2, calculated 390.0782, 
measured 390.0788; IR: 1707.3 cm
-1
 (film). 
2,2′-(4-chlorophenyl)acetyl disulfide: as above using sodium 
hydrosulfide (1.6 g, 29.25 mmol) in ethanol; (15 ml) 4-
chlorophenylacetic acid (2 g, 11.7 mmol) in DCM (20 ml); Ghosez 
reagent (1.72 g, 1.57 ml, 12.9 mmol); iodine (0.5 g, 3.9 mmol) to 
give product (1.5 g, 4.1 mmol, 70.1 % yield). HPLC retention time 
7.3 min; 
1
H NMR (CDCl3, 400MHz) δ 3.94 (s, 4H, CH2), 7.17-7.39 7.52 
(d,d, 8H, J1 8.28 Hz, J2 92.54 Hz, ArH) ppm; 
13
C NMR (CDCl3, 
100MHz) δ 48.37 (CH2), 129.12 (CH), 130.48 (Cq), 131.06 (CH), 
134.12 (Cq), 190.83 (CO) ppm. HRMS (m/z): [M+NH4]
+
 for 
C16H12Cl2O2S2, calculated 387.9994, measured 388.0000; IR: 
1720.2cm
-1
 (film). 
2,2′-(4-cyanophenyl)acetyl disulfide: as above using sodium 
hydrosulfide (2.4 g, 43 mmol) in ethanol (20 ml); 4-
cyanophenylacetic acid (2.753 g, 17.1 mmol) in DCM (20 ml); 
Ghosez reagent (3.432 g, 3.120 ml, 25.7 mmol); iodine (0.5 g, 3.9 
mmol) to give the product as a oragne/yellow solid (1.6 g, 4.6 
mmol, 53.8 % yield). HPLC retention time 6.0 min; 
1
H NMR (CDCl3, 
400MHz) δ 4.08 (s, 4H), 7.53 (d,d, 8H, J1 8.06 Hz, J2 92.53 Hz, ArH) 
ppm; 
13
C NMR (CDCl3, 100MHz) δ 48.82 (CH2), 112.06 (CN), 118.41 
(Cq), 130.47 (CH), 132.65 (CH), 137.28 (Cq), 189.76 (CO) ppm. HRMS 
(m/z): [M+NH4]
+
 for C18H12N2O2S2, calculated 352.0340, measured 
352.0352; IR: 1715.6 cm
-1
 (film). 
2,2′-(4-methoxyphenyl)acetyl disulfide: as above using sodium 
hydrosulfide (4.26 g, 75.3 mmol) in ethanol (20 ml); 4-
methoxyphenylacetic acid (5 g, 30.1 mmol) in DCM (20 ml); Ghosez 
reagent (8.03g, 7.96 ml, 60.2 mmol); iodine (1 g, 7.8 mmol) to give 
product (1.19 g, 3.28 mmol, 10.9 % yield). 
1
H NMR (CDCl3, 400MHz) 
δ 3.79 (s, 6H, CH3), 3.92 (s, 4H, CH2), 7.04 (d,d, 8H, J1 8.75 Hz, J2 
114.31, ArH) ppm; 
13
C NMR (CDCl3, 100MHz) δ 48.6 (CH3), 55.2 
(CH2), 114.7 (CH), 124.5 (Cq), 131.1 (CH), 159.5 (Cq), 192.5 (CO) 
ppm; HRMS (m/z): [M+NH4]
+
 for C18H18O4S2, calculated 362.0647, 
measured 362.0634. 
Bis-benzoyl disulfide
39
: To sodium sulfide (1.84g, 23.6mmol) in 
water (12ml) and heated to 50
o
C was added tetra-N-
butylammonium bromide (380mg, 1.18mmol) then stirred for 30 
minutes. In a separate flask, (fitted with an exhaust line allowing 
any gasses generated to be scrubbed by sodium hypochlorite in a 
well-ventilated fume hood) benzoyl chloride (2ml, 1.65g, 11.8mmol) 
in toluene (12ml). This was chilled in an ice bath. After 30 minutes 
the sodium sulfide solution was cooled to room temperature and 
slowly added to the rapidly stirring, chilled benzoyl chloride solution 
under a nitrogen atmosphere creating a biphasic reaction mixture. 
This was stirred for 24 hours at room temperature. The organic and 
aqueous layers were separated, the aqueous layer washed with 2 x 
5ml portions of toluene and the organic layers combined. The 
toluene was then removed under vacuum giving the product as 
white crystals (738mg, 45.7% yield) from which a single crystal X-ray 
diffraction pattern was resolved. The aqueous layer contains 
residual Na2S which will generate H2S if exposed to acid and was 
disposed of carefully. 
1
H NMR (CDCl3, 400MHz) δ  7.43 (t, 4H, ArH), 
7.57 (t, 2H, ArH), 7.89 (d, 4H, ArH)ppm; 
13
C NMR (CDCl3, 100MHz) δ  
127.91 (CH), 128.79 (CH), 134.02 (CH), 136.61 (Cq), 190.37 (CO) 
ppm. 
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